News

Aclys Bio to Attend BIO 2022 Convention

May 21, 2022 Aclys Bio

Aclys Bio will be attending the 2022 BIO International Convention in San Diego June 13 – 16. Aclys will be scheduling meetings with a number of potential partners to discuss Aclys’s pipeline of antibody-based therapeutics for Precision Oncology. If you would like to schedule a meeting with Aclys Bio, please […]

Aclys Bio and Genmab Enter Research and Commercial License Option Agreement

January 27, 2022 Aclys Bio

Aclys Bio Corp (“Aclys”), a company discovering and developing precision biologics for the treatment of cancer, today announced a new exclusive research and commercial license option agreement with Genmab A/S (Nasdaq: GMAB), an international biotech company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Enquire now

Give us a call or fill in the form below and we'll contact you. We endeavor to answer all inquiries within 24 hours on business days.

info@aclys.bio